The limited specificity of the PSA test results in overdiagnosis (unnecessary prostate biopsies) and consequently, the overtreatment of subjects with a low-potential malignant tumor, or with a low potential for morbidity or death if left untreated [4,5]. Here, KLK3 is linked to cancer.